Results 211 to 220 of about 31,766 (260)

Safety monitoring of the RTS,S/AS01_E malaria vaccine: experiences and lessons from routine pharmacovigilance in Ghana, Kenya, and Malawi. [PDF]

Malar J
Ashie A, Mandale M, Ndalama A, Darko D, Seaneke S, Boateng EK, Sabblah G, Asamoa-Amoakohene A, Amponsa-Achiano K, Mohammed NT, Jalang'o R, Nkansah E, Adu-Boahen Y, Siyoi F, Toroitich A, Khaemba C, Nambwa P, Jain S, Okine RNA, Mssusa AK.   +19 more
europepmc   +1 more source

Predicting Serious Adverse Events, Medication Abuse, Misuse, and Risk of Dependence for Medications with High Dependence Potential: Role of Patient-Reported Factors and Machine Learning Approach. [PDF]

Healthcare (Basel)
Kim Y, Sohn YJ, Yoo JY, Kim M, Kim S, Choi YJ.   +5 more
europepmc   +1 more source

Pharmacovigilance of paracetamol-induced Stevens-Johnson Syndrome and toxic epidermal necrolysis in the Indian population.

Indian J Pharmacol
Ray RS, Yadav A, Bhushan S, Prakash J, Raghuvanshi RS.   +4 more
europepmc   +1 more source

Hematological toxicities in bevacizumab associated with ovarian cancer: A pharmacovigilance study using FDA adverse event reporting system database. [PDF]

Medicine (Baltimore)
Zhou X, Su L, Lin Y, Cheng Z, Du Z, Han B, Wang X.   +6 more
europepmc   +1 more source

A pharmacovigilance study of sirolimus-associated adverse events in organ transplantation. [PDF]

Front Immunol
Yi DZ, Jiao Y, Xiu CF, Han L, Li SL, Sun XF, Liu B.   +6 more
europepmc   +1 more source

Hepatic adverse effects of valproic acid: Management strategies.

Indian J Pharmacol
Bouaziz I, Atheymen R, Sahnoun R, Ksouda K, Affes H, Hammami S, Zghal K.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

The history of pharmacovigilance

Therapie, 2016
This article reviews the main historical events before the 21st century and explained their consequences in the current pharmacovigilance legislation.
Michael Rochoy, Sophie Gautier
exaly   +3 more sources

Pharmacovigilance in Perspective

Drug Safety, 1999
Pharmacovigilance is more than spontaneous reporting alone, and the evaluation of marketed medicines is more than just pharmacovigilance. The positioning of a drug usually takes place during the years following introduction, when worldwide experience has accumulated.
Meyboom, R.H.B., Egberts, A.C.G., Gribnau, F.W.J., Hekster, Y.A.   +3 more
openaire   +4 more sources